(Q37324637)

19 August 2017

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma (English)

1 reference

Mucin 16, cell surface associated

19 August 2017

0 references

1 reference

1 reference

M W McIntosh

1

1 reference

19 August 2017

C Drescher

2

1 reference

19 August 2017

B Karlan

3

1 reference

19 August 2017

N Scholler

4

1 reference

19 August 2017

N Urban

5

1 reference

19 August 2017

K E Hellstrom

6

1 reference

19 August 2017

I Hellstrom

7

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

19 August 2017

1 reference

19 August 2017

95

1 reference

19 August 2017

1

1 reference

19 August 2017

9-15

1 reference

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Molecular cloning and expression of megakaryocyte potentiating factor cDNA

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Generating longitudinal screening algorithms using novel biomarkers for disease.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Screening for ovarian cancer: a pilot randomised controlled trial.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Quantifying the potential benefit of CA 125 screening for ovarian cancer

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Combining several screening tests: optimality of the risk score.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Factors influencing serum CA125II levels in healthy postmenopausal women.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734270

Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.07.039

Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15385104

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15385104

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2004.07.039

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

15385104

1 reference